ASO Author Reflections: Evaluation of Tumor Regression After Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma-How to Do It?

被引：2

作者：

Takeda, Flavio Roberto ^{[1
]}

Tustumi, Francisco ^{[1
]}

Cecconello, Ivan ^{[1
]}

机构：

[1] Univ Sao Paulo, Med Sch, Dept Gastroenterol, Digest Surg Div, Sao Paulo, Brazil

来源：

ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / 04期

关键词：

D O I：

10.1245/s10434-019-08016-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1248 / 1249

页数：2

共 50 条

[1] ASO Author Reflections: Evaluation of Tumor Regression After Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma—How to Do It?
Flavio Roberto Takeda
Francisco Tustumi
Ivan Cecconello
Annals of Surgical Oncology, 2020, 27 : 1248 - 1249
[2] ASO Author Reflections: Intensified Neoadjuvant Chemoradiotherapy Followed by Esophagectomy in Esophageal Cancer
Boers, Jorianne
de Groot, Jan Willem B.
ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (05) : 1529 - 1529
[3] ASO Author Reflections: Intensified Neoadjuvant Chemoradiotherapy Followed by Esophagectomy in Esophageal Cancer
Jorianne Boers
Jan Willem B. de Groot
Annals of Surgical Oncology, 2020, 27 : 1529 - 1529
[4] ASO Author Reflections: Exploring the Best Parameter for Lymph Node Assessment in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy
Huang, Xu
Tan, Lijie
ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (02) : 1292 - 1293
[5] ASO Author Reflections: Exploring the Best Parameter for Lymph Node Assessment in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy
Xu Huang
Lijie Tan
Annals of Surgical Oncology, 2024, 31 : 899 - 900
[6] ASO Author Reflections: Preservation of the Thoracic Duct is Feasible for Esophageal Squamous Cell Carcinoma Patients Treated with Esophagectomy After Neoadjuvant Chemoradiotherapy
Oshikiri, Taro
Numasaki, Hodaka
Oguma, Junya
Toh, Yasushi
Watanabe, Masayuki
Muto, Manabu
Kakeji, Yoshihiro
Doki, Yuichiro
ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (05) : 2699 - 2700
[7] ASO Author Reflections: Preservation of the Thoracic Duct is Feasible for Esophageal Squamous Cell Carcinoma Patients Treated with Esophagectomy After Neoadjuvant Chemoradiotherapy
Taro Oshikiri
Hodaka Numasaki
Junya Oguma
Yasushi Toh
Masayuki Watanabe
Manabu Muto
Yoshihiro Kakeji
Yuichiro Doki
Annals of Surgical Oncology, 2023, 30 : 2699 - 2700
[8] ASO Author Reflections: Fathoming the Dilemma of the Optimal Time to Surgery for Patients with Resectable Esophageal Cancer After Neoadjuvant Chemoradiotherapy
Li, Jingqiu
Wang, Qifeng
ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (06) : 3852 - 3853
[9] ASO Author Reflections: Fathoming the Dilemma of the Optimal Time to Surgery for Patients with Resectable Esophageal Cancer After Neoadjuvant Chemoradiotherapy
Jingqiu Li
Qifeng Wang
Annals of Surgical Oncology, 2024, 31 : 3852 - 3853
[10] ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
Hiroshi Okumura
Masahiro Noda
Shoji Natsugoe
Annals of Surgical Oncology, 2018, 25 : 715 - 716

← 1 2 3 4 5 →